Walleye Capital’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Walleye Capital’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36K	Hold	284,345	–	–	﹤0.01%	4602
2026 Q1	$5.86K	Hold	284,345	–	–	﹤0.01%	4191
2025 Q4	$6.91K	Sell	284,345 -309,286	-52%	-$10.1K	﹤0.01%	4321
2025 Q3	$23.3K	Sell	593,631 -49,216	-8%	-$1.92K	﹤0.01%	4188
2025 Q2	$25.3K	Sell	642,847 -23,122	-3%	-$962	﹤0.01%	4200
2025 Q1	$31.3K	Sell	665,969 -5,774	-0.9%	-$375	﹤0.01%	3944
2024 Q4	$23K	Sell	671,743 -49,162	-7%	-$2.4K	﹤0.01%	4485
2024 Q3	$50.5K	Hold	720,905	–	–	﹤0.01%	4638
2024 Q2	$43.8K	Hold	720,905	–	–	﹤0.01%	4967
2024 Q1	$216K	Sell	720,905 -15	-0%	-$5	﹤0.01%	3930
2023 Q4	$353K	Sell	720,920 -39,671	-5%	-$11K	﹤0.01%	3233
2023 Q3	$129K	Buy	760,591 +45,557	+6%	+$7.18K	﹤0.01%	3811
2023 Q2	$136K	Hold	715,034	–	–	﹤0.01%	3303
2023 Q1	$39.5K	Buy	+715,034	New	+$138K	﹤0.01%	3257

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Walleye Capital's RCKTW Position: Q2 2026 in Review

Walleye Capital held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q2 2026 at 284,345 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4602.

Walleye Capital first reported a position in RCKTW in Q1 2023 and has held it in 14 quarters since. The position peaked at $353K in Q4 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

Walleye Capital held 284,345 shares of Rocket Pharmaceuticals Warrant worth $1.36K as of Q2 2026.
Walleye Capital left its Rocket Pharmaceuticals Warrant share count unchanged in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4602 holding.
Walleye Capital first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and has held it in 14 quarters since.
Walleye Capital's Rocket Pharmaceuticals Warrant position peaked at $353K in Q4 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.